Arbutus Biopharma(us:ABUS)

    3.18

    -0.93%

    Updated on 2024-12-23

    Open:3.19
    Close:3.18
    High:3.24
    Low:3.15
    Pre Close:3.21
    Volume:292526.00
    Amount:937966.13
    Turnover:0.15%
    Shares:190.66M
    MarketCap:606.25M

    About Arbutus Biopharma Company

    Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

    Company Name: Arbutus Biopharma
    Company Address: 701 Veterans Circle
    Employees: 73
    Fiscar Year: 12-31
    IPO Date: 2007-07-20
    CIK: 1447028

    View all SEC Filings

    About

    Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
    Address:701 Veterans Circle

    Market Movers